Lili Mu Selected Research

Lili Mu Research Topics

Disease

11	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2021 - 06/2008
9	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 02/2020 - 09/2009
8	Neoplasms (Cancer) 01/2022 - 10/2009
6	Autoimmune Diseases (Autoimmune Disease) 12/2019 - 06/2008
3	Inflammation (Inflammations) 07/2020 - 01/2016
3	Myasthenia Gravis 10/2019 - 09/2009
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Demyelinating Diseases (Demyelinating Disease) 08/2021 - 01/2021
2	Glioma (Gliomas) 07/2020 - 07/2016
2	Multiple Sclerosis 12/2019 - 01/2013
2	Stroke (Strokes) 11/2015 - 04/2014
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Adenocarcinoma 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Reperfusion Injury 12/2020
1	Infarction (Infarctions) 10/2020
1	Infections 07/2020
1	Melanoma (Melanoma, Malignant) 07/2020
1	Hypoxia (Hypoxemia) 12/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Vascular Diseases (Vascular Disease) 11/2015
1	Brain Ischemia (Cerebral Ischemia) 11/2015
1	Ischemic Stroke 11/2015
1	Starvation 11/2015
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Ischemia 04/2014
1	Carcinogenesis 10/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2010
1	Hepatocellular Carcinoma (Hepatoma) 10/2009

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2008
7	CytokinesIBA 08/2021 - 06/2008
3	MicroRNAs (MicroRNA)IBA 08/2021 - 12/2019
3	Cholinergic ReceptorsIBA 06/2019 - 05/2012
2	AutoantigensIBA 12/2019 - 09/2009
2	Freund's AdjuvantIBA 11/2018 - 10/2018
2	Interleukin-9 (Interleukin 9)IBA 10/2018 - 11/2014
2	InterleukinsIBA 10/2018 - 06/2008
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 10/2011
2	Transcription Factors (Transcription Factor)IBA 07/2016 - 09/2015
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016 - 05/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2013 - 04/2013
2	Peptides (Polypeptides)IBA 04/2013 - 05/2012
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Opioid Peptides (Opioid Peptide)IBA 08/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	human PRMT2 proteinIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	ChromatinIBA 01/2021
1	EnzymesIBA 01/2021
1	coactivator-associated arginine methyltransferase 1IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Histocompatibility Antigens Class IIIBA 12/2020
1	GTP Phosphohydrolases (GTPases)IBA 07/2020
1	OsteopontinIBA 02/2020
1	AntigensIBA 12/2019
1	Interleukin-2 (IL2)IBA 12/2019
1	AutoantibodiesIBA 10/2019
1	AMP-Activated Protein KinasesIBA 10/2019
1	Metformin (Glucophage)FDA LinkGeneric 10/2019
1	ChlorophyllIBA 10/2018
1	peridininIBA 10/2018
1	isothiocyanic acidIBA 10/2018
1	cyanine dye 3IBA 10/2018
1	incomplete Freund's adjuvantIBA 10/2018
1	AntibodiesIBA 10/2018
1	allophycocyaninIBA 10/2018
1	InterferonsIBA 10/2018
1	Mercaptoethanol (2 Mercaptoethanol)IBA 10/2018
1	OvalbuminIBA 10/2018
1	Phosphates (Orthophosphate)IBA 10/2018
1	PhycoerythrinIBA 10/2018
1	Bovine Serum AlbuminIBA 10/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 10/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2018
1	Janus KinasesIBA 10/2018
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2016
1	CalciumIBA 01/2016
1	SaltsIBA 11/2015
1	p38 Mitogen-Activated Protein KinasesIBA 11/2015
1	Sodium Chloride FDA LinkGeneric 11/2015
1	SodiumIBA 11/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 08/2014
1	triphenyltetrazoliumIBA 04/2014
1	Vitamin A (Retinol)FDA LinkGeneric 08/2013
1	LigandsIBA 10/2011
1	Receptor for Advanced Glycation End ProductsIBA 10/2011
1	CarcinogensIBA 10/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2010
1	Hemagglutinins (Hemagglutinin)IBA 10/2009
1	Mannose (D-Mannose)IBA 10/2009
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2009

Therapy/Procedure

2	Electroacupuncture 08/2021 - 01/2013
2	Therapeutics 10/2009 - 09/2009
1	Acupuncture Points (Acupuncture Point) 08/2021
1	Transplantation 01/2021
1	Ligation 11/2015
1	Drug Therapy (Chemotherapy) 09/2015